This unique report provides information and analysis not available from any other published source.
The report is available by section, and can be customized to specific information needs and budget.
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 292 pages and 36 tables
The report is available by section, and can be customized to specific information needs and budget.
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:
- Hospitals - Public Health Labs - Commercial/Private Labs
- Blood Banks - Physician Offices - Ambulatory Care Centers
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 292 pages and 36 tables
Companies Mentioned
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako